RU2012119761A - METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN - Google Patents
METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN Download PDFInfo
- Publication number
- RU2012119761A RU2012119761A RU2012119761/15A RU2012119761A RU2012119761A RU 2012119761 A RU2012119761 A RU 2012119761A RU 2012119761/15 A RU2012119761/15 A RU 2012119761/15A RU 2012119761 A RU2012119761 A RU 2012119761A RU 2012119761 A RU2012119761 A RU 2012119761A
- Authority
- RU
- Russia
- Prior art keywords
- day
- occurrence
- treatment
- twice
- metronidazole
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ лечения для предупреждения возникновения онкологических заболеваний у человека, включающий проведение медикаментозной терапии, отличающийся тем, что проведение медикаментозной терапии осуществляют в виде систематического профилактического лечения у лиц мужского один раз в квартал, начиная с 12 лет, семейной пары двухкратно перед зачатием, в целях предупреждения возникновения онкологических заболеваний у малолетних детей и возникновения онкологических заболеваний у женщин, путем введения в первый день внутривенно по 100 мл метрогила трехкратно через 8 ч, во второй день внутривенно по 100 мл метрогила двухкратно вводить через 12 ч, одновременно внутрь вводить йодит калия или аспаркам, на третий день и в течении семи дней два раза в день после еды внутрь по 0,5 г сульфадемитоксина и по 0,5 г метронидазола, причем до 15 лет половина указанной нормы, а именно по 0,25 г сульфадемитоксина и 0,25 г метронидазола, на десятый день лечения внутривенно 100 мл метрогила однократно, причем на весь период лечения обеспечивать обильным питьем в виде отвара из кураги и чернослива с оральным введением мочегонных лекарственных средств.A treatment method for preventing the occurrence of oncological diseases in humans, including carrying out drug therapy, characterized in that the drug therapy is carried out in the form of systematic preventive treatment in male individuals once a quarter, starting at age 12, of a married couple twice before conception, in order to prevent the occurrence of cancer in young children and the occurrence of cancer in women, by the introduction of 100 ml of meth ogila three times after 8 hours, on the second day, intravenously, 100 ml of metrogyl is administered twice after 12 hours, at the same time, potassium iodite or asparca are administered orally, on the third day and within seven days, twice a day after meals, 0.5 g sulfamemitoxin inside and 0.5 g of metronidazole, and up to 15 years, half of the indicated norm, namely 0.25 g of sulfademititoxin and 0.25 g of metronidazole, on the tenth day of intravenous treatment, 100 ml metrogil once, and for the entire treatment period, provide plenty of drink in the form decoction of dried apricots and prunes with oral BB deniem diuretic drugs.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012119761/15A RU2012119761A (en) | 2012-05-14 | 2012-05-14 | METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012119761/15A RU2012119761A (en) | 2012-05-14 | 2012-05-14 | METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012119761A true RU2012119761A (en) | 2013-11-20 |
Family
ID=49555092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012119761/15A RU2012119761A (en) | 2012-05-14 | 2012-05-14 | METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2012119761A (en) |
-
2012
- 2012-05-14 RU RU2012119761/15A patent/RU2012119761A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015023910A2 (en) | claudin 18.2 antibody therapy for cancer treatment | |
EA201491334A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | |
RU2018123666A (en) | METHOD FOR TREATING CANCER IN A MAMMAL, INCLUDING A HUMAN, WITH APPLICATION OF DEPLETION OF METHIONINE AND ASPARAGIN | |
EA201491427A1 (en) | SUBSTITUTED PHENYLIMIDAZOPIRAZOLES AND THEIR APPLICATION | |
JP2017061488A5 (en) | ||
RU2012119761A (en) | METHOD OF TREATMENT FOR PREVENTING ONCOLOGICAL DISEASES IN HUMAN | |
RU2012119763A (en) | METHOD OF TREATING MEN FOR THE BIRTH OF HEALTHY MOTION | |
RU2012112098A (en) | METHOD FOR INCREASING SURGERY OF THE SKIN FLAP IN THE CONDITIONS OF REDUCED BLOOD CIRCULATION BY MINOXIDYL | |
RU2011101090A (en) | METHOD FOR INFLAMMATORY INTESTINAL DISEASES THERAPY | |
RU2016147455A (en) | METHOD FOR TREATMENT OF SKIN MANIFESTATIONS OF SCLERODERMA | |
Kakar et al. | Hypersensitivity to romidepsin | |
RU2012127605A (en) | METHOD FOR TREATING HIV INFECTED PERSON | |
Mirza | A Review on the Chemical versus Alternative Treatments of Leukemia | |
UA117784U (en) | METHOD OF PREVENTION OF RECURRENCE OF HYPERPLASTIC PROCESSES IN WOMEN IN PREMENOPAUSE | |
MY159675A (en) | Clerodane derivatives for modulation of leukotriene receptor activity and related diseases | |
RU2011138424A (en) | METHOD FOR PREVENTION OF MYOCARDIAL INFARCTION, ISCHEMIC AND HEMORRHAGIC STROKES | |
RU2010118309A (en) | METHOD FOR INCREASING HUMAN MENTAL PERFORMANCE | |
UA69674U (en) | method for treatment of erythematous-bullous erysipelas | |
UA129564U (en) | METHOD OF COMPLEX PREVENTION OF VITAMIN D DEFICIENCY AFFECTING CALCULATION, MAGNESIUM, ZINC IN PREGNANT WOMEN | |
UA112314U (en) | METHOD OF MEDICAMENTOUS CORRECTION OF PSYCHOEMOTIONAL SPHERE IN PATIENTS WITH ARTERIAL HYPERTENSION | |
Zeng | Leukaemoid reaction secondary to hypersensitivity syndrome: case report | |
UA112971U (en) | METHOD OF MEDICAL REHABILITATION OF SPORTSMEN WHO TAKE INTENSIVE PHYSICAL LOADS, WITH THE SIGNIFICANCE OF IMMUNODEFICITIS AND ENDOGENOCOGENIC | |
UA103397U (en) | A method of treating chronic trichomoniasis | |
Pristenska et al. | Pharmacological activity of ointment “Allergolic” on the model of contact allergic dermatitis | |
Philpott | Wellbeing colds and flu: Achoo! What do you do?: Add that extra care... |